Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of colestilan versus placebo in dialysis patients with hyperphosphataemia and dyslipidaemia
2006-006535-53Phase 3Completed
- Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Start
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hyperphosphatemia, lipid disorder and chronic kidney disease (CKD) comparing Colestilan fixed-dose groups with Placebo (2 arms). Primary endpoints: Change from baseline in serum phosphorus and Percent change from baseline in serum LDL-C. Started Jul 2007; status: completed.
02
Drugs
colestilan
03
Conditions
hyperphosphatemialipid disorderchronic kidney disease (CKD)
Beyond the preview
Go deeper on 2006-006535-53.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006535-53.